|
Status |
Public on Mar 16, 2011 |
Title |
DLBCL patient_A0020379 |
Sample type |
RNA |
|
|
Source name |
DLBCL
|
Organism |
Homo sapiens |
Characteristics |
pfs.status: 1 pfs.time: 73 response: SD spdpct: -48.96 classspd10: 1 sgn40dx: 1
|
Treatment protocol |
Patients were all treated with SGN-40
|
Extracted molecule |
total RNA |
Extraction protocol |
total cellular RNA were extracted with mirVanaTM miRNA Isolation Kit (Ambion, Austin, TX)
|
Label |
biotin
|
Label protocol |
according to the manufacturer’s instruction
|
|
|
Hybridization protocol |
according to the manufacturer’s instruction
|
Scan protocol |
according to the manufacturer’s instruction
|
Description |
A0020379
|
Data processing |
Expression was normalized and estimated using VSN.
|
|
|
Submission date |
Oct 02, 2009 |
Last update date |
Mar 16, 2011 |
Contact name |
Peng Yue |
E-mail(s) |
[email protected]
|
Phone |
650-467-3587
|
Organization name |
Genentech Inc
|
Street address |
1 DNA Way
|
City |
South San Francisco |
State/province |
CA |
ZIP/Postal code |
94080 |
Country |
USA |
|
|
Platform ID |
GPL6244 |
Series (1) |
GSE18376 |
Gene expression profiling of human DLBCL tumor samples (SGN-40 trial) |
|